abrdn Healthcare Investors 

Tekla Healthcare Investors is a closed-end investment fund, which engages in investing in the healthcare industry including biotechnology, medical devices, and pharmaceuticals. Its objective is to provide long-term capital appreciation through investments in companies in the healthcare industry. The company was founded on October 31, 1986 and is headquartered in Boston, MA.

Virtus Artificial Intelligence & Technology Opportunities Fund

Global X Artificial Intelligence & Technology ETF

ProShares Ultra Nasdaq Biotechnology

ProShares Ultra Oil & Gas

Eaton Vance Enhanced Equity Income Fund

Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund

Eaton Vance Tax-Managed Global Diversified Equity Income Fund

iShares Nasdaq Biotechnology ETF

Intel

iShares Russell 2000 ETF

NVIDIA

Novo Nordisk

Invesco QQQ

First Trust Cloud Computing ETF

SPDR S&P 500 ETF Trust

ProShares Ultra S&P 500

Energy Select Sector SPDR Fund

Exxon Mobil

In Part I of my Top Picks For 2024, I explained why we saw such extreme valuation losses in most equity CEFs in 2023 and what that could-mean for 2024. In my opinion, liquidity was the over-riding factor for why so few stocks, think Magnificent 7, received the lion's share of buy-interest while most everything else suffered, including equity CEFs. But just because the Federal Reserve will continue its Quantitative Tapering doesn't mean that other Fed programs won't increase liquidity in other places.

Equity CEFs/ETFs: Top Picks For 2024 - Part II

abrdn Healthcare Investors continues to face pressure as healthcare and biotech sectors remain out of favor. HQH remains an attractive buy if one believes that the healthcare and biotech space can rebound in time and also offers a significant discount. HQH offers an attractive distribution while waiting for the sector to turn around to more favorable times.

HQH: Remains Beaten Down But Also Remains An Interesting Prospect

How's the colder weather treating you? Fighting a cold? I get paid by the healthcare sector, and every year, I'm reminded why exposure to this sector is a must. Let the doctors and big pharma pay for your retirement.

HQH: I Am Getting A 9.5% Yield On My Last Buy

abrdn Healthcare Investors is a closed-ended fund focused on the global biotech & healthcare sector boasting a 10% dividend yield. The recent acquisition of Tekla Capital Management's funds by abrdn will not change the operations and strategies of HQH. HQH is currently trading at a 17.28% discount to NAV, indicating a potential 10% upside to historical averages, making it an attractive investment opportunity.

HQH: Discount To NAV Offers Attractive Entry Opportunity

abrdn Healthcare Investors fund (formerly Tekla Healthcare Investors) has been taken over by abrdn and renamed. However, day-to-day management remains the same. The HQH fund's heavy exposure to biotechnology has led to sub-par returns due to higher interest rates and poor equity risk appetites. Until those macro drivers change, I continue to recommend caution with the HQH fund.

HQH: New Name But Same Risky Bets On Biotech

BlackRock Energy and Resources Trust

I often get asked if you can retire just on dividends. And the answer is yes – yes, you can. Over 50% of Americans are not saving properly for retirement. The three-legged stool approach is dead. It's time to adapt.

Yes, You Can Retire On Dividends, 2 Big Yields Up To 11%

abrdn Life Sciences Investors 

abrdn World Healthcare Fund 

PHILADELPHIA, PA / ACCESSWIRE / October 27, 2023 / Effective close of business today, October 27, 2023, abrdn Inc. ("abrdn") assumed responsibility for the management of the four (4) former Tekla Capital Management LLC closed-end funds totaling $2.8bn in assets under management (AUM) as of October 26, 2023. As noted within the Funds' proxy statements and in connection with the change in investment adviser, each Fund amended its declaration of trust to change its name as detailed in the chart below effective after close of regular business on October 27, 2023.

abrdn Announces Its Appointment to Four U.S. Specialist Healthcare Closed-End Funds, New Board of Trustees to the Funds and Fund Name Changes

BOSTON--(BUSINESS WIRE)--Tekla Capital Management LLC (Tekla) announced today that the requisite vote has been attained to approve the new investment advisory agreement with abrdn Inc. for each of its four closed-end funds (the Funds). The Funds are: Tekla Healthcare Investors (HQH) Tekla Life Sciences Investors (HQL) Tekla Healthcare Opportunities Fund (THQ) Tekla World Healthcare Fund (THW) Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW) approved the proposal a.

Tekla Funds Approve New Investment Advisory Agreements With abrdn Inc.

Tekla Capital Management LLC (Tekla) announced today that it has completed the sale of its advisory business to abrdn Inc. In addition, effective close of regular business, abrdn was approved as manager to four NYSE listed healthcare and biotech thematic closed-end funds, totaling $2.8 bn in assets under management (AUM) as of October 26, 2023.

Tekla Capital Management LLC Announces Closing of Transaction With abrdn

Adams Diversified Equity Fund

Blackrock Health Sciences Trust

BlackRock Science & Technology

BlackRock Science and Technology Trust II

BlackRock Utilities Infrastructure & Power Opportunities Trust

ClearBridge Energy MLP Fund Inc

Central Securities

European Equity Fund

Franklin Templeton Emerging Markets Fund

Eaton Vance Tax Advantaged Global Dividend Opportunities Fund

Eaton Vance Tax-Advantaged Dividend Income Fund

Sprott Focus Trust

General American Investors

Gabelli Dividend & Income Trust

Gabelli Global Small and Mid Cap Value Trust

Eagle Capital Growth Fund Inc

Gabelli Healthcare & Wellness Trust

India Fund Inc

Morgan Stanley India Investment Fund Inc

Barings Corporate Investors

Barings Participation Investors

Mexico Fund

PIMCO Energy and Tactical Credit Opportunities Fund

Income Portfolio - 38 CEFs Worth Exploring

BOSTON--(BUSINESS WIRE)--Tekla Healthcare Investors (HQH) today announced at the Special Meetings of shareholders (“Special Meetings”) that the requisite vote had been attained for the proposal to approve the new investment advisory agreement with abrdn Inc. However, while the proposal has now been passed for both HQH and for Tekla Life Science Investors (HQL) at its meeting held on October 3rd, the new investment advisory agreement with abrdn Inc., and the related benefits that will accrue to.

Tekla Funds Implore Shareholders of THQ and THW to Vote Immediately to Realize Potential Cost Savings for the Funds

BlackRock Resources & Commodities Strategy Trust

Seasonal changes can drive income higher in your portfolio. Two excellent picks for the end of the year. Caught a cold? Thank you for buying products that help yourself - and me!

Buy These 2 Magnificent Yields, Even If You Buy Nothing Else In October

Healthcare - we all need it, we all pay for it. You can receive outstanding income from this beaten-down sector. Stop just paying your medical bills; have those medical bills pay you.

2 Magnificent Passive Income Stocks, Up To 12% Yield

BOSTON--(BUSINESS WIRE)--On September 29, 2023, Tekla Healthcare Investors paid a distribution of $0.40 per share. It is currently estimated that this distribution is derived from net realized long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of.

Tekla Healthcare Investors Paid Distribution

Gilead Sciences

Illumina

IQVIA Hlds

Direxion Daily S&P Biotech Bull 3X Shares

Lonza Group AG

Merck

Navistar

Omega Healthcare Investors

Pfizer

Royalty Pharma

Wuxi Biologics Cayman Inc

SPDR S&P Biotech ETF

Health Care Select Sector SPDR Fund

The recent IRA list of 10 drug publications is not expected to have a significant impact on big pharma stocks in the near term. The legal challenges by big pharma companies against the IRA may derail the implementation of the drug pricing reforms. Investors can consider diversified biotech indexes or healthcare-focused ETFs for exposure to the biopharma sector.

Biopharma Bounce-Back: From Policy Pains To Profitable Plains

BOSTON--(BUSINESS WIRE)--Tekla Healthcare Investors (HQH), Tekla Life Sciences Investors (HQL), Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW), (the “Funds”) today announced that their joint first special meetings of shareholders (“Special Meetings”) were adjourned for a second time until September 12, 2023 at 9:00 a.m. EDT due to lack of a quorum on the proposal to approve a new investment advisory agreement with abrdn, Inc. Shareholders as of the June 16, 2023.

Tekla Funds Announce Second Adjournment of Special Meetings and Urge Shareholder Participation to Limit the Need for Further Solicitation Efforts

BOSTON--(BUSINESS WIRE)--On August 15, 2023, Tekla Healthcare Investors declared a distribution of $0.40 per share. The record date for the distribution is August 25, 2023 and the payable date is September 29, 2023. The Fund will trade ex-distribution on August 24, 2023. Under its distribution policy, the Fund intends to make quarterly distributions at a rate of 2% of the Fund's net assets. Therefore, when the net assets of the Fund are down, the distribution per share amount will decrease and.

Tekla Healthcare Investors Declares Distribution

BOSTON--(BUSINESS WIRE)--Tekla Healthcare Investors (HQH), Tekla Life Sciences Investors (HQL), Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW), (the “Funds”) today announced that their joint special meetings of shareholders on August 14, 2023 (“Special Meetings”) were adjourned until August 29, 2023 to provide additional time for the Funds to reach a quorum on the proposal, described in their definitive joint proxy statement dated July 10, 2023 as filed with the.

Tekla Funds Announce Adjournment of Special Meetings

America faces a silver tsunami as baby boomers enter retirement age. Healthcare costs have outpaced inflation over the past decades, and the trend will continue. Invest in this complex sector with expert-driven diversification and +9% yields.

Healthcare Dividends: Investing In The Lifeline Of Aging America

Tekla Healthcare Investors, a closed-end fund, focuses on the biotech subsector of healthcare, leading to potential volatility but also potential for high returns. The fund's deep discount presents an opportunity for investors after a down year for biotech, but a dollar-cost averaging approach could be a better approach due to volatility. HQH's managed distribution plan provides investors with a distribution yield while waiting through biotech cycles, with long-term capital gains making up the bulk of the distribution classification.

HQH: Deep Discount Presents An Opportunity

Charlie Munger, vice chairman of Berkshire Hathaway Inc., brings a wealth of investment wisdom, priceless for those who seek to learn. Everyone has different requirements and priorities; we will mimic, but not mirror, his investing style.

Invest Like Charlie Munger With 4 Criteria

You want exposure to the healthcare sector in your retirement portfolio. HQH fund has a 35-year track of outperforming and returning value to investors.

4 Reasons HQH Is Great For Retirement Portfolios

Antero Midstream Partners

W. P. Carey

There are generally two separate issues with respect to leaving an estate – spouses and everyone else. Spouses should generally plan to generate enough income to sustain the longer-lived spouse – this means that the spouse who passes first must leave an estate.

Leaving Something Behind For Heirs: How Dividends Beat Annuities

Antero Resources

Legendary fund manager John Neff was a fan of big yields. Investment success does not require glamour stocks or bull markets. - John Neff.

Big Opportunity In The Panic: 2 Fat Yields Up To 9%

The HQH fund aims to provide high total returns through investments in the healthcare industry. HQH has a high allocation to risky biotech stocks and private investments. The fund pays a 2% of NAV quarterly distribution. However, HQH has under-earned relative to its distribution in the past 5 years.

News for abrdn Healthcare Investors ETF (HQH)